Cyclerion Therapeutics, Inc.
General ticker "CYCN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $7.5M (TTM average)
Cyclerion Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -21.1%.
Estimated limits based on current volatility of 3.7%: low 1.52$, high 1.64$
Factors to consider:
- Total employees count: 1 as of 2024
- Top business risk factors: Limited operating history and no commercial products, Significant losses, Need for additional capital, Regulatory and compliance, Economic downturns and volatility
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.84$, 5.14$]
- 2025-12-31 to 2026-12-31 estimated range: [1.35$, 3.91$]
Financial Metrics affecting the CYCN estimates:
- Positive: with PPE of -2.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -53.83 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Shareholder equity ratio, % of 92.43 > 63.39
Short-term CYCN quotes
Long-term CYCN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.30MM | $0.00MM | $2.00MM |
| Operating Expenses | $18.84MM | $12.95MM | $5.63MM |
| Operating Income | $-18.54MM | $-12.95MM | $-3.63MM |
| Non-Operating Income | $0.29MM | $0.36MM | $0.57MM |
| R&D Expense | $5.98MM | $1.51MM | $0.29MM |
| Income(Loss) | $-18.25MM | $-12.59MM | $-3.06MM |
| Other Income(Loss) | $-25.83MM | $7.33MM | $0.00MM |
| Profit(Loss)* | $-69.91MM | $2.07MM | $-3.06MM |
| Stockholders Equity | $10.45MM | $11.29MM | $8.85MM |
| Assets | $18.08MM | $13.37MM | $9.57MM |
| Operating Cash Flow | $-40.61MM | $-21.25MM | $-4.33MM |
| Investing Cash Flow | $0.00MM | $10.40MM | $0.00MM |
| Financing Cash Flow | $0.03MM | $5.02MM | $0.00MM |
| Earnings Per Share** | $-32.17 | $0.88 | $-1.21 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.